US 6,720,356 B2Granted

Magnesium di-potassium EDTA complex and method of administration

OwnerSpencer Feldmaninventor

Life of this patent

Estimating the term…

Abstract

A composition containing an EDTA complex in the form of a suppository is provided. More specifically, the EDTA complex is a magnesium di-potassium EDTA complex. The suppository may contain a controlled release agent which will release the EDTA complex over a period of several hours.

Claims3

Dependent claims

A method of administering a magnesium di-potassium EDTA complex to a patient, comprising the steps of:

(a) forming a suppository consisting essentially of containing magnesium di-potassium EDTA and
(b) administering said suppository to the patient.

Dependencies are inferred from the claim text.

Facts

Application: 10/124,763Filed 19 Apr 2002 · us provisional application
Priority: 20 Apr 2001
Published: US 2002/0169211 A114 Nov 2002
Granted: 13 Apr 2004
Term ends: Not estimatedThe source records don’t support an estimate.

Classification4 codes

A61K 31/195
Carboxylic acids, e.g. valproic acid: having an amino group
A61K 9/0031
Galenical forms characterised by the site of application: rectum, anus
A61K 31/198
The amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine,…:…
A61K
Medicines and medical preparations

Family

Application60/285,546Us provisional application · filed 20 Apr 2001
US 2002/0169211 A1Pre-grant publication · published 14 Nov 2002
US 6,720,356 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results